Huna
Sao Paulo company founded in 2022 that applies AI to routine blood tests, starting with the complete blood count, to flag early cancer risk; the platform turns laboratory data patients already generate into multi-cancer screening across breast, cervical, colorectal, lung and prostate indications.
Headquarters
Sao Paulo, Brazil
Year Founded
2022
Founders
Vinicius Ribeiro (CEO), Daniella Castro (CTO)
Country
Brazil
Financial Information
Funding Stage
Pre-Seed
Recent Funding
$1.5M
Funding By
Kortex Ventures, big_bets, Niu Ventures, New Ventures Capital
Core Technology
Machine learning on routine laboratory blood data for early cancer detection
Product Type
AI Platform
Pipeline Stage (Very Important)
Regulatory Status
- IND Filed: N/A
- FDA/EMA Status: N/A
- Clinical Trial Registration: N/A
- Patents / IP Status: Not disclosed
Partnerships
Pharma Collaborations
Not disclosed
Academic / Hospital Tie-ups
Not disclosed
CRO/CDMO Partnerships
None disclosed
Market & Differentiation
Multi-cancer screening from tests patients already take, needing no new instrumentation